--- title: "Evaluation of Buvidal" ocid: "ocds-kuma6s-127356" canonical_url: "https://d3tenders.com/contract/?ocid=ocds-kuma6s-127356" markdown_url: "https://d3tenders.com/contract/ocds-kuma6s-127356.md" json_url: "https://d3tenders.com/contract/ocds-kuma6s-127356.json" source: "Sell2Wales" current_stage: "Award" buyer: "LLYWODRAETH CYMRU / WELSH GOVERNMENT" published: "2023-03-08" --- # Evaluation of Buvidal Buyer: LLYWODRAETH CYMRU / WELSH GOVERNMENT Current stage: Award OCID: ocds-kuma6s-127356 [View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-kuma6s-127356) [Download OCDS JSON](https://d3tenders.com/contract/ocds-kuma6s-127356.json) ## Summary The Welsh Government has awarded a contract for the Evaluation of Buvidal to USW Commercial Services Ltd. The evaluation focuses on the rapid implementation of Injectable Buprenorphine (Buvidal) as part of opioid substitution treatment (OST) services. The contract, valued at £399,990, was signed on 8th March 2023. The procurement process was completed under the open procedure for services. The evaluation includes stages to assess setup, theory of change, and overall effectiveness of Buvidal, offering business growth opportunities in the healthcare services sector. This tender by the Welsh Government presents opportunities for businesses in the healthcare and pharmaceutical sectors to engage in the evaluation of cutting-edge medical interventions like Buvidal. With a strong emphasis on effectiveness assessment and economic evaluation, businesses with expertise in healthcare research, intervention evaluation, and service effectiveness measurement would be well-suited to bid for this contract. The inclusion of community benefits and consortia bidding further widens the scope for business growth and collaboration in this competitive procurement process. ## Notice The Welsh Government (WG) wishes to commission an evaluation of the rapid implementation of Injectable Buprenorphine (Buvidal) which forms part of the range of interventions within opioid substitution treatment (OST) services. Buvidal is a new form of OST which replaces the need for daily supervised consumption with weekly or monthly injections. ### Lot Information Lot 1 The Welsh Government (WG) wishes to commission an evaluation of the rapid implementation of Injectable Buprenorphine (Buvidal) which forms part of the range of interventions within opioid substitution treatment (OST) services. Buvidal is a new form of OST which replaces the need for daily supervised consumption with weekly or monthly injections. The evaluation will have both backward - and forward - looking components and will serve three aims: Stage one: To assess how the programme has been set up and how it is being operated (backward looking). Stage one will also be used to assess the feasibility of adopting a randomised controlled trial methodology for stage three and/or suggest other models if appropriate. Stage two: To elucidate the theory of change for Buvidal and develop the logic model underpinning the treatment, considering the differences between Buvidal and other OST and what the 'new' service should look like. Stage three: To provide an indication of its overall effectiveness and an economic evaluation (including any differences between outcomes for those on Buvidal and other OST medications). Renewal: An extension of up to a further 24 months. ## Key Details | Field | Value | | --- | --- | | Publication source | Sell2Wales | | Latest notice | https://www.sell2wales.gov.wales/search/search_switch.aspx?ID=127356 | | Notice type | OJEU - F3 - Contract Award Notice | | Procurement type | Standard | | Procurement category | Services | | Procurement method | Open | | Procurement method details | Open procedure | | Tender suitability | Not specified | | Awardee scale | Large | | All stages | Tender, Award | ## Dates | Field | Value | | --- | --- | | Publication date | 8 Mar 2023 | | Submission deadline | 6 Feb 2023 | | Future notice date | Not specified | | Award date | 8 Mar 2023 | | Contract period | Not specified | | Recurrence | Not specified | ## Values | Field | Value | | --- | --- | | Tender value | £650,000 | | Lots value | Not specified | | Awards value | Not specified | | Contracts value | £399,990 | ## Status | Field | Value | | --- | --- | | Tender status | Complete | | Lots status | Complete | | Awards status | Not specified | | Contracts status | Active | ## Buyer | Field | Value | | --- | --- | | Main buyer | LLYWODRAETH CYMRU / WELSH GOVERNMENT | | Locality | CAERDYDD / CARDIFF | | Post town | Cardiff | | Postcode | CF10 3NQ | | Country | Wales | | ITL 1 | TLL Wales | | ITL 2 | TLL5 South East Wales | | ITL 3 | TLL52 Cardiff and Vale of Glamorgan | | Local authority | Cardiff | | Electoral ward | Cathays | | Westminster constituency | Cardiff South and Penarth | | Delivery location | TLL Wales | ## Supplier | Field | Value | | --- | --- | | Number of suppliers | 1 | | Supplier names | USW COMMERCIAL SERVICES | ## CPV Codes ### Divisions - 73 - Research and development services and related consultancy services - 79 - Business services: law, marketing, consulting, recruitment, printing and security ### Codes - 73000000 - Research and development services and related consultancy services - 73100000 - Research and experimental development services - 73110000 - Research services - 73200000 - Research and development consultancy services - 73210000 - Research consultancy services - 79300000 - Market and economic research; polling and statistics - 79310000 - Market research services - 79315000 - Social research services ## Release History - 8 Mar 2023 at 00:00 - Award - OJEU - F3 - Contract Award Notice - https://www.sell2wales.gov.wales/search/search_switch.aspx?ID=127356 - 15 Dec 2022 at 00:00 - Tender - OJEU - F2 - Contract Notice - https://www.sell2wales.gov.wales/search/search_switch.aspx?ID=127356 ## Documents - https://www.sell2wales.gov.wales/search/show/search_view.aspx?ID=DEC421678 Evaluation of Buvidal - The Welsh Government (WG) wishes to commission an evaluation of the rapid implementation of Injectable Buprenorphine (Buvidal) which forms part of the range of interventions within opioid substitution treatment (OST) services. Buvidal is a new form of OST which replaces the need for daily supervised consumption with weekly or monthly injections. - https://www.sell2wales.gov.wales/search/show/search_view.aspx?ID=MAR430249 Evaluation of Buvidal - The Welsh Government (WG) wishes to commission an evaluation of the rapid implementation of Injectable Buprenorphine (Buvidal) which forms part of the range of interventions within opioid substitution treatment (OST) services. Buvidal is a new form of OST which replaces the need for daily supervised consumption with weekly or monthly injections. ## Notice URLs - http://gov.wales - http://www.sell2wales.gov.wales/search/search_switch.aspx?ID= - https://api.sell2wales.gov.wales/v1?lang=cy/Notice?id=ocds-kuma6s-127356 - https://etenderwales.bravosolution.co.uk - https://www.etenderwales.bravosolution.co.uk ## Provenance This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-kuma6s-127356. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-kuma6s-127356.json.